Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31 Mar 2026 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|
| Revenue | 1.41B | 1.30B | 1.23B | 1.17B | 1.13B | 1.08B |
| Cost of revenue | 723M | 668M | 626M | 591M | 555M | 527M |
| Gross profit | 684M | 632M | 603M | 582M | 579M | 556M |
| Research and development | 262M | 262M | 243M | 254M | 262M | 243M |
| Selling, general and administrative | 103M | 108M | 102M | 92M | 106M | 114M |
| Operating expenses | 577M | 591M | 566M | 558M | 584M | 575M |
| Operating income | 108M | 41M | 37M | 23M | −5M | −19M |
| Pre-tax income | 102M | 33M | 34M | 27M | −4M | −26M |
| Income tax | 12M | −5M | 11M | 7M | 6M | 6M |
| Net income | 90M | 37M | 22M | 20M | −10M | −32M |
| Earnings per share | 0.59 | 0.24 | 0.15 | 0.13 | −0.06 | −0.19 |
| Earnings per share, diluted | 0.57 | 0.23 | 0.14 | 0.12 | −0.06 | −0.19 |
| Weighted average shares | 152M | 153M | 153M | 153M | 159M | 170M |
| Weighted average shares, diluted | 158M | 159M | 160M | 162M | 159M | 170M |
| Metric | 31 Mar 2026 | 31 Dec 2025 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 31 Dec 2024 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 542M | 682M | 735M | 969M | 467M | 421M | 584M | 755M |
| Receivables | 711M | 637M | 613M |
| Metric | 31 Mar 2026 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | 153M | — | — | 191M | — | — |
| Depreciation and amortisation | 34M | — | — | 50M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 588M |
| 578M |
| 589M |
| 551M |
| 537M |
| Current assets | 3.45B | 3.58B | 3.48B | 3.53B | 3.47B | 3.45B | 3.55B | 3.96B |
| Goodwill | 5.29B | 5.29B | 5.24B | 5.24B | 5.24B | 5.24B | 5.24B | 5.24B |
| Total assets | 9.58B | 9.77B | 9.71B | 9.85B | 9.81B | 9.87B | 10.04B | 10.51B |
| Current liabilities | 740M | 887M | 742M | 720M | 726M | 820M | 701M | 711M |
| Long-term debt | 993M | 992M | 992M | 991M | 991M | 991M | 990M | 990M |
| Total liabilities | 1.79B | 1.95B | 1.82B | 1.80B | 1.81B | 1.91B | 1.81B | 1.83B |
| Equity | 7.78B | 7.82B | 7.90B | 8.04B | 8.00B | 7.95B | 8.23B | 8.68B |
| Shares outstanding | — | 152M | — | — | — | 153M | — | — |
| Shares issued | — | 152M | — | — | — | 153M | — | — |
| — |
| — |
| Share-based compensation | 137M | 158M | 149M | 139M | 155M | 148M |
| Investing cash flow | −41M | — | — | −19M | — | — |
| Share buybacks | 253M | — | — | 126M | — | — |
| Financing cash flow | −253M | — | — | −126M | — | — |